158 related articles for article (PubMed ID: 37561345)
1. Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.
Ramalingam K; Clelland E; Rothschild H; Mujir F; Record H; Kaur M; Mukhtar RA
Ann Surg Oncol; 2023 Nov; 30(12):7099-7106. PubMed ID: 37561345
[TBL] [Abstract][Full Text] [Related]
2. Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome.
van Hemert A; van Loevezijn AA; Bosman A; Vlahu CA; Loo CE; Peeters MTFDV; van Duijnhoven FH; van der Ploeg IMC
Breast Cancer Res Treat; 2024 Apr; 204(3):497-507. PubMed ID: 38189904
[TBL] [Abstract][Full Text] [Related]
3. Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
Lips EH; Mukhtar RA; Yau C; de Ronde JJ; Livasy C; Carey LA; Loo CE; Vrancken-Peeters MJ; Sonke GS; Berry DA; Van't Veer LJ; Esserman LJ; Wesseling J; Rodenhuis S; Shelley Hwang E;
Breast Cancer Res Treat; 2012 Nov; 136(1):35-43. PubMed ID: 22961065
[TBL] [Abstract][Full Text] [Related]
4. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
[TBL] [Abstract][Full Text] [Related]
6. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
[TBL] [Abstract][Full Text] [Related]
7. Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer.
Petrelli F; Barni S
Breast Cancer Res Treat; 2013 Nov; 142(2):227-35. PubMed ID: 24177758
[TBL] [Abstract][Full Text] [Related]
8. Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.
Cocquyt VF; Blondeel PN; Depypere HT; Praet MM; Schelfhout VR; Silva OE; Hurley J; Serreyn RF; Daems KK; Van Belle SJ
Eur J Surg Oncol; 2003 May; 29(4):361-7. PubMed ID: 12711290
[TBL] [Abstract][Full Text] [Related]
9. Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.
Delpech Y; Coutant C; Hsu L; Barranger E; Iwamoto T; Barcenas CH; Hortobagyi GN; Rouzier R; Esteva FJ; Pusztai L
Br J Cancer; 2013 Feb; 108(2):285-91. PubMed ID: 23299541
[TBL] [Abstract][Full Text] [Related]
10. Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery-A systematic review and meta-analysis.
O'Connor DJ; Davey MG; Barkley LR; Kerin MJ
Breast; 2022 Feb; 61():1-10. PubMed ID: 34864494
[TBL] [Abstract][Full Text] [Related]
11. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Neoadjuvant Chemotherapy on Margin Re-excision in Breast-Conserving Surgery.
Devane LA; Baban CK; O'Doherty A; Quinn C; McDermott EW; Prichard RS
World J Surg; 2020 May; 44(5):1547-1551. PubMed ID: 32002582
[TBL] [Abstract][Full Text] [Related]
13. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial.
Olson JA; Budd GT; Carey LA; Harris LA; Esserman LJ; Fleming GF; Marcom PK; Leight GS; Giuntoli T; Commean P; Bae K; Luo J; Ellis MJ
J Am Coll Surg; 2009 May; 208(5):906-14; discussion 915-6. PubMed ID: 19476859
[TBL] [Abstract][Full Text] [Related]
14. Rationale for Mastectomy after Neoadjuvant Chemotherapy.
Gusic LH; Walsh K; Flippo-Morton T; Sarantou T; Boselli D; White RL
Am Surg; 2018 Jan; 84(1):126-132. PubMed ID: 29428039
[TBL] [Abstract][Full Text] [Related]
15. Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).
Mukhtar RA; Hoskin TL; Habermann EB; Day CN; Boughey JC
Ann Surg Oncol; 2021 Oct; 28(11):5867-5877. PubMed ID: 33687613
[TBL] [Abstract][Full Text] [Related]
16. Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
Lohani KR; Hoskin TL; Day CN; Yasir S; Boughey JC; Degnim AC
Ann Surg Oncol; 2024 Feb; 31(2):936-946. PubMed ID: 37872454
[TBL] [Abstract][Full Text] [Related]
17. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.
Boughey JC; Wagner J; Garrett BJ; Harker L; Middleton LP; Babiera GV; Meric-Bernstam F; Lucci A; Hunt KK; Bedrosian I
Ann Surg Oncol; 2009 Jun; 16(6):1606-11. PubMed ID: 19280264
[TBL] [Abstract][Full Text] [Related]
19. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
[TBL] [Abstract][Full Text] [Related]
20. Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma.
Wanis ML; Wong JA; Rodriguez S; Wong JM; Jabo B; Ashok A; Lum SS; Solomon NL; Reeves ME; Garberoglio CA; Senthil M
Am Surg; 2013 Oct; 79(10):1119-22. PubMed ID: 24160812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
